NHLBI Announces Two New Funding Opportunities
The National Heart, Lung, and Blood Institute (NHLBI) has recently released two new Funding Opportunity Announcements (FOAs): Catalyzing Innovation in Late Phase Clinical Trial Design. The purpose of these FOAs is to provide support for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the NHLBI and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation.
To apply, click on the FOA and complete the form:
Deadlines to Submit Applications for each are: July 19, 2018, and October 19, 2018